Gecko has developed a cloud-based solution to simplify chronic respiratory disease management through remote monitoring.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has entered into a definitive agreement to acquire Gecko Health Innovations Inc. Based in Cambridge, Massachusetts, Gecko is a privately-held company, which develops software and product solutions to aid in compliance and adherence improvement in the management of respiratory diseases. No financial details about the acquisition were disclosed.
Gecko CEO and founder Engelhard said, "During the last three years, we have designed and built a system to support respiratory disease management by intuitively connecting caregivers, patients, and families. In founding Gecko Health Innovations, our vision was to connect chronic medication management into one platform, leveraging this information to support and empower patients by partnering with leading players in the healthcare and pharmaceutical industries. We are very excited to realize this vision as it aligns to Teva's focus on innovative patient solutions."